From an update, "April 05, 2013:
NanoLogix plans to begin marketing this summer of their new N-Assay Multiwell Diagnostic test."
Commish posted , "I guess you have to define what the term "marketing" really meant. The new update clearly describes
A quick look on the internet gives this definition of Marketing…..the activities that are involved in making people aware of a company's products, making sure that the products are available to be bought, etc.
Keembodakine, just look at his reply, he goes off on himself when you ask him a question. And he is one to complain about others so called BS ?
erickarther wrote "About time you chirped in with a dumb negative post ....... Omar you insignificant troll, "
The lack of results shown by the company is the NEGATIVE and that's why the PPS is where it's at. And about being insignificant, I'm sure you think you're one of the best posters here with your nothing to add but insults directed toward other posters. And you call another poster a troll ? LOL
Erickarther wrote " I'm ordering you to get to work, NOW....... LOL"
Looking at the last financials put out perhaps you should direct that toward the company ?
Without numbers to back up the interest then what good is the interest ? Talk needs to be in the form of Sales numbers to really mean something.
Perhaps the latest news would be more exciting if there was news on how well the sales were going with these guys in the last year or so.
NanoLogix, an innovator in the rapid detection, identification and determination of antibiotic resistance and sensitivity of live bacteria, announces that they have signed a distribution agreement with IVD Tech Private Ltd of Singapore. This distribution agreement provides IVD Tech with exclusive distribution rights for sales of NanoLogix products in a number of Asian countries. The agreement was finalized and signed in Hubbard Ohio with the help of Mousa Kassis, representative of the Ohio International Trade Assistance Center (ITAC) housed at Youngstown State University.
IVD Tech Private Ltd. Executive Directors James Sim and Charlton Kwan, who traveled from Singapore to NanoLogix headquarters in Ohio for the signing, made the following joint statement:
"NanoLogix possesses an amazing technology in their rapid live-cell bacteria and microorganism detection kits. Together with patented Extended Life (EL) packaging technology, IVD Tech strongly believes that NanoLogix's live-cell rapid detection kits and EL packaging technology is going to be a game changer in the diagnostics and petri plate technology space.
IVD Tech is extremely blessed and excited to be NanoLogix's Asia partner. Engagement has already started with potential channel partners and end users in Singapore, Japan, China and other countries.
IVD Tech's headquarters is purposely located in Singapore, a business and financial hub for Asia. Both NanoLogix and IVD Tech value Singapore's strong intellectual property protection, and close ties and proximity to other Asian countries. IVD Tech is to become the window and platform for Nanologix to access into the Asia region."
mistevfel posted ""The Company... anticipates... sublicensing for use and manufacture to a group or groups in the region".
Key word " anticipates ", next question is if sales come from it will the company put that news out, regardless if it's significant or not ? I "anticipate" if the sales aren't significant they won't.
wdb1 posted " I get the impression that NNLX has essentially become a petri dish selling company - though they don't even appear to be selling very many of those."
Closing in on 1 year since this below, supposedly there is an N-Assay out there. But seems N-Assay sure is taking it's time.
"Nanologix® News wire:
NanoLogix to Exhibit at BioOhio Exposition, Receives European Allowance for BNP Patent
NanoLogix Inc. (NNLX), an innovator in the rapid detection of viable bacteria, and identification and determination of antibiotic resistance/sensitivity of those bacteria, announces that it is exhibiting at the BioOhio BioScience Expo and Showcase to be held in Aurora, Ohio on August 5th at the Bertram Conference Center. Sebastian Faro MD., PhD, a highly recognized authority on infectious diseases of female reproductive systems, will be presenting on the NanoLogix N-Assay Multiwell Microplate Assay during the event.
Just as easily as they put numbers out about 20,30,40 and 50 plates they could have put numbers out how much those current customers were buying. And even put a number out what they think potential customer will buy. That is what I think people really want to hear. How difficult is that to do ?
"This move is done to assist high-use current and potential customers in reducing both their labor for handling in the laboratory and overall packaging waste disposal costs.'
They will put this out but how about showing the numbers in sales of those high-use current customers are buying ? If the number is great then it should give some confidence back to the stock price, right ?
Over 3 years ago…..
"NanoLogix’s management is focused on positioning our BNP and BNF technology to enter and capture a significant portion of that market. We believe that businesses, and indeed whole industries, that need or supply diagnostics will choose our faster, simpler and cheaper technology over expensive, highly complex equipment that cannot differentiate between live active-threat and dead bacteria."
And yet where is any sales of BNF at ? And how's BNP doing ? Capturing a significant portion are they ? Hmmm ? So much faster,simpler and cheaper over stuff that can't differentiate between live active-threat and dead bacteria ?? How could it not generate significant sales, right ?
it's getting pretty dark in here, isn't it ? It appears this is what happens when someone talks dominating markets( investors believing it) and yet in reality there is little if anything to show to the investors after all this time.
There hasn't been any news with the EPA and Nanologix yet ?
It's been 2 years since this came out June 2013, and that release talked about their existing CRADA ? Seems 2 years has past by and nothing ? So is that the end of that road Nanologix was hoping to get sales from ?
"NanoLogix Inc. (NNLX), an innovator in the accelerated detection, identification and antibiotic sensitivity determination of live bacteria, announces that the US Environmental Protection Agency and NanoLogix have agreed to extend their existing Cooperative Research and Development Agreement (CRADA) for two years, with the new expiration being mid-2015. The CRADA is focused on using NanoLogix-based technologies for development of a comprehensive water quality test kit for testing drinking and source waters in all ten EPA regions.
It's not like the company isn't doing it's part to keep it going, pending update now been on the website for over 1 full month. Keeping the "any day now" thing going I guess ?
What would be a real scream of a laugh would the look on the face of that woman who was talking about $2/share not too long ago. 3 cents must have her in shock.
Commish wrote "Perhaps a follow-up article or operations update would clarify how things are going in mid 2015"
Did you see this from the Website ?
Tryptic Soy Agar (TSA100) for sampling (3 plates for free)
I wonder how that is working out for more sales for those ?